Urogene is a drug development company. We identify compounds with potential interest in the urology field ; implement preclinical and clinical programs to obtain drug candidates with clinical proof-of-concept of efficacy and safety.

Out-licensing

We propose partnering opportunities to any urology-oriented company for late-stage clinical development of our drug candidates. Out-licensing, co-development, commercialization or corporate agreements can be considered.

In-licensing

We continuously seek to identify new opportunities to in-license compounds with potential interest in our therapeutic areas. These can be late-stage preclinical candidates or drugs that are/were developed or marketed in other indications. Partnering or merging with companies in related areas of specialization can also be considered, as makes most business sense.

For business enquiries, please contact Pierre Attali at p.attali@urogene.com